Table 1.
Number of screening samples |
|||||
---|---|---|---|---|---|
Company/institute | aSample type (number) | Extracts (sample source #) | Fractions (extract source #) | Compounds (type) | Ref. |
| |||||
Albany Molecular Research, Inc. (AMRI) | B/F and P (>190 000) | 102 000 (23 375) | 209 000 (12 349) | — | 205 |
AnalytiCon Discovery | B/F (na); P (na); SS (>25 000) | — | — | >25 000 (SS); >5000 (NP) | 206 |
bBioinformatics Institute Singapore (BII)—A*STAR Natural Product Library | B/F (>120 000); P (>37 000) | ∼270 000 (>157 000) | ∼70 000 (na) | 2600 (NP) | 207 |
cDevelopmental Therapeutics Program—The National Cancer Institute | MI (>20 000); B/F (>25 000); P (>80 000) | >230 000 (>108 000) | 326 000 (46 570) | 419 (NP set IV)d | 26 |
fFondazione Ricerca per la Vita (FIIRV) | B/F (>15 000) | 166 000 (15 000) | — | — | 208 |
Fundación MEDINA | B/F (190 000) | >130 000 (na) | — | — | 209 |
Griffith Institute for Drug Discovery (GRIDD)—Nature Bank | MI and P (30 000) | 10 000 (10 000) | 50 000 (10 000) | 210 | |
InterBioScreen (IBS) | MI (na); B/F (na) and P (na) | — | — | >67 000 (NP) | 211 |
Magellan BioScience Group, Inc. | MB (10 000); F (55 000) | >15 000 (na) | — | — | 212 |
Mycosynthetix | F (>55 000) | 55 000 (na) | — | — | 213 |
eNatural Products Discovery Institute (NPDI) | B/F (>30 000); P (>20 000) | 80 000 (na) | — | — | 214 |
fPharmaMar | MI (>118 000); MB (>100 000) | 100 000 (na) | — | — | 215 |
PhytoPharmacon | P (4000) | 4000 (4000) | 25 000 (4000) | 500 (NP) | 216 |
RIKEN Natural Products Repository (NPDepo) | B/F (na) and P (na) | — | — | 8000 (NP) | 217 |
The Institut de Chimie des Substances Naturelles (ICSN) | MI, B/F, and P (>7000) | 14 000 (7000) | — | — | 218 |
The Natural Products Library Initiative at the Scripps Research Institute (Florida) | B (>5500) | 8500 (na) | 3400 (na) | 450 (NP) | 219 |
The University of Mississippi—National Center for Natural Products Research | MI and F (>2000); P (>18 000) | >20 000 (>20 000) | >43 000 (>3400) | ∼700 (NP) | 220 |
Unigen (PhytoLogix Library) | P (8000) | 9000 (na) | 200 000 (na) | — | 221 |
B = bacteria; F = fungi; MB = marine bacteria; MI = marine invertebrates; P = plant; NP = pure natural products; SS = semi-synthetic (NP-based); na = data not available.
Acquired from MerLion Pharmaceuticals (Singapore).
No cost for materials, recipients only cover shipping charges.
The current Natural Products Set IV was selected from the DTP Open Repository Collection of >4500 pure natural product compounds.
Former Merck and Schering-Plough Natural Product Libraries.
Accessed through InterLink Biotechnologies.222